Canadian research peptides · independently tested
Canada’s most documented peptide source — 244 independent lab reports, a published purity floor of 93.844%, and domestic shipping.
We are an affiliate: if you order from Growth Guys using this code we earn a commission, at no extra cost to you. We are not Growth Guys and have no ownership of or role in the company.
How to know if a peptide company is legit — last verified at checkout at Growth Guys (growthguys.com): October 11, 2026 (today), 15:31 ET — HEALTHYLIFE10 applied and working, taking $4.00 CAD off a $40.00 CAD cart, exactly 10% off sitewide, with no minimum purchase and no product exclusions; 2 live-cart checks so far today.
A five-point check anyone can run in ten minutes: lab domain vs vendor-hosted PDF, batch-number match, report count, shipping origin, and whether the discount survives a live cart test.
| Cart subtotal | Discount | Paid | Rate |
|---|---|---|---|
| $90.00 CAD | −$9.00 CAD | $81.00 CAD | 10.0% |
| $175.00 CAD | −$17.50 CAD | $157.50 CAD | 10.0% |
| $40.00 CAD | −$4.00 CAD | $36.00 CAD | 10.0% |
| $80.00 CAD | −$8.00 CAD | $72.00 CAD | 10.0% |
| $40.00 CAD | −$4.00 CAD | $36.00 CAD | 10.0% |
Each row: one cart, built October 9, 2026, at a value chosen to differ from the others. A code with an undisclosed floor passes any single-value test, which is why this one varies. No order, no payment details — guest-cart figures only.
Add anything to the cart, enter HEALTHYLIFE10 in the discount field at the cart stage, and confirm the discount line changes before you continue. No account and no sign-in are needed; the code applies to a guest cart, and it is reusable, so it behaves the same on a second order as a first.
244 published lab reports. 133 distinct products covered. 99.03% average purity across the 181 reports that state one, spanning 93.844% to 99.99%. Every one of them is hosted by Janoshik Analytical rather than by the seller, which is what makes the figures checkable instead of quotable. Shipping is domestic Canadian, pricing CAD, and the vendor has answered in public threads since November 2021. Itemised here.
Before any laboratory document enters the picture, a seller has already told you a great deal through its published policies. Does it state where it ships and where it will not? Does it say what happens when something arrives wrong, in terms specific enough to be held to? Is the returns position stated plainly, even when the answer is unfavourable?
A policy that is unfavourable but explicit is a better sign than one that is vague and warm. "All sales are final" is a real commitment you can price into the decision. "Customer satisfaction is our priority" commits to nothing and cannot be breached, which is precisely why it is everywhere.
Ask something specific and mildly inconvenient before you order. Which batch will ship for this product? Can you send the report for that batch? What happens if the vial arrives broken? These are ordinary questions with short answers if the operation is what it claims, and they are slow and evasive if it is not.
The content of the reply matters less than its shape. A seller testing per production run can name your batch, because the document already exists. One that tested once and has been reusing the certificate cannot, and will answer a different question than the one you asked — usually by restating a general quality claim. That substitution is the signal.
Pricing far below the rest of the market is information, not a bargain. Independent assay, cold-chain handling and per-batch documentation all cost money, and a seller substantially cheaper than everyone else has either found an efficiency or stopped paying for one of those things. It is worth knowing which.
Honest stock reporting is an underrated tell in the same family. A catalogue where nothing is ever out of stock, across dozens of items, is describing a supply chain that does not exist. Visible out-of-stock listings and visible batch turnover are small signs that what you are reading reflects a real inventory rather than a storefront.
The first is treating presentation as evidence. A polished site, a professional-looking certificate and a confident tone take the least effort to produce of anything on this list, and they correlate with nothing. The second is treating any single gap as proof of bad faith: a missing report on a newly listed product is far more often a documentation lag than a concealment.
What survives both errors is a short list of things that are checkable rather than impressive: a stated shipping route you can confirm on your first tracking number, a testing claim you can verify on a laboratory's own domain, a batch code that matches, and policies specific enough to be wrong. Weigh those and discount the rest.
Most of the checks above can be completed in an afternoon, which is their strength and also their limit — a storefront built last month can pass all of them. The signal that is genuinely hard to fabricate is a record that extends backwards: batch numbers advancing over months, reports dated across a long period, products visibly moving in and out of stock.
This is the one test that costs an operator real time rather than real money, which is why it is worth weighting heavily. You do not need to wait yourself; you need to look at whether the published record shows a history. A set of documents all dated within a few weeks of each other describes a launch, not a track record, and there is nothing wrong with a launch so long as you know that is what you are buying into.
Yes. It was cart-tested on October 11, 2026 and took $4.00 CAD off a $40.00 CAD cart at growthguys.com — exactly 10%. This page is rebuilt from that test, so the date above is when it was last confirmed, not when it was written.
Weight the things you can check over the things that impress. Stated shipping routes confirmed by your own tracking, testing you can verify on a laboratory's own domain, batch codes that match your vial, and policies specific enough to be breached. Site design and certificate styling prove nothing.
Ask which batch will ship and request the report for that specific batch. A seller testing per production run can answer immediately because the document exists. One reusing a single certificate will answer a more general question instead, and that substitution is the signal.
It is information worth following up. Independent testing, proper handling and per-batch documentation cost money, so a seller well below the market has either found a genuine efficiency or stopped paying for one of them.